Mammalian target of rapamycin signaling in diabetic cardiovascular disease
about
Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTORErythropoietin and diabetes mellitusStem cell guidance through the mechanistic target of rapamycinFoxO Transcription Factors and Regenerative Pathways in Diabetes MellitusErythropoietin: new directions for the nervous systemCutting through the complexities of mTOR for the treatment of strokeTargeting disease through novel pathways of apoptosis and autophagyErythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life ExpectancyNew Insights for Oxidative Stress and Diabetes MellitusNovel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic diseaseCharacterization of the specificity of O-GlcNAc reactive antibodies under conditions of starvation and stress.PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotectionOvernutrition, mTOR signaling, and cardiovascular diseases.The prevention of diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth factor is probably mediated by the suppression of oxidative stress and damageRegeneration in the nervous system with erythropoietinA Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascadeWnt1 inducible signaling pathway protein 1 (WISP1) targets PRAS40 to govern β-amyloid apoptotic injury of microglia.Novel directions for diabetes mellitus drug discoveryDetecting DNA synthesis of neointimal formation after catheter balloon injury in GK and in Wistar rats: using 5-ethynyl-2'-deoxyuridine.Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia.A novel AKT inhibitor, AZD5363, inhibits phosphorylation of AKT downstream molecules, and activates phosphorylation of mTOR and SMG-1 dependent on the liver cancer cell type.Serum pigment epithelium-derived factor levels are independently correlated with the presence of coronary artery disease.Rapamycin, Autophagy, and Alzheimer's DiseaseMammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Mesoglycan attenuates VSMC proliferation through activation of AMP-activated protein kinase and mTOR.Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.Target acquired: Selective autophagy in cardiometabolic disease.Rapamycin alleviates oxidative stress-induced damage in rat erythrocytes.Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.γ-Oryzanol Enhances Adipocyte Differentiation and Glucose Uptake.mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.Folic acid inhibits dedifferentiation of PDGF-BB-induced vascular smooth muscle cells by suppressing mTOR/P70S6K signalingActivation of mTOR signaling mediates the increased expression of AChE in high glucose condition: in vitro and in vivo evidences.Rapamycin protects testes against germ cell apoptosis and oxidative stress induced by testicular ischemia-reperfusion.Rhodiola crenulata Attenuates High Glucose Induced Endothelial Dysfunction in Human Umbilical Vein Endothelial Cells.
P2860
Q26749047-D0B13887-4C44-44C3-BF0D-537F679F123EQ26777878-677EBD15-C733-4EED-A478-226668788D70Q26795544-CF923159-97D2-41AD-8277-C6F7D95CC590Q26800615-5377B3C1-769B-4C12-A361-73D417076FA2Q26828425-EE338390-C9FA-4AA7-8DE6-ED1FED9653FCQ26851291-211F7723-66FE-4474-9A62-F4677A6DD6F8Q26864639-E2BC32C6-7694-475A-93C6-693B59D3538BQ28066377-B5AA40E3-028F-49E1-8CA1-2A7EECE45BACQ28080679-8A5FFEDF-B9D3-410C-BACB-01902F31DA04Q28085715-587C3E1B-654F-4AFF-864D-4366A94DD589Q33964124-6AC1530C-7E6D-4753-8C15-D5921F936985Q34429082-6C76DC68-2DE0-439C-A054-3FCA64475348Q34519316-B7495ECB-5B5B-4B9A-987E-63C96FCCE9C4Q35070159-33899AF7-2812-471F-BE70-F916CABBA01AQ36247651-AB13C229-D09A-44F1-9961-9724EA135233Q36379761-9037BC88-67A4-4ED5-87DF-8F758C6F45CDQ36432388-1DB9ACE5-F9C7-471C-959A-2A6DC5EA0038Q36465550-51737084-D5BC-476D-BF41-E880600502BCQ36487424-C5C24494-FCAB-4F96-B30B-DB9837E25637Q36510193-038D8058-0F09-4A1D-909D-CC026B7B0EFFQ36597635-5CEB0D4E-B369-495F-9C75-564F3F3EC759Q36640327-A4A9B694-7E3A-4807-97D6-F93F567E01BCQ36766879-A490252F-9ED5-4A2D-BF6F-9BA15EAD9DEAQ36971857-50C884FD-19CC-4F86-88D9-5C701C35A7DBQ37583506-34D592DD-70AF-4DA2-A6E3-05E653196967Q38367977-FEE1A400-6630-47B0-AA9D-6DA3F9F98AB6Q38368556-AABB540A-78E2-4227-B8D8-322BDF87BECBQ38607849-F0929F00-15CA-4ACD-9D8C-A04C4432FDA6Q38655453-185C2AA6-4A65-4923-AB7B-36826D475464Q38659874-EF00564E-1EDA-43EC-B0E7-E1C75D017954Q38789540-8DF9073E-1C17-4072-9CE5-8AAA46E1EE84Q39155198-4C3F2AB6-94B4-4812-BEAD-7DAA8EEB7291Q39385462-62DABBB2-F178-4C6F-A94B-688DA5DA8E81Q41082884-4AF95234-7260-48F6-A636-A7FB7561AF32Q41501785-E8EE2864-D6CE-4A3C-BFA4-DB44E4B5798BQ42031136-954A9C2C-D1A7-4510-8B7B-CB4F8ECAE02FQ42068247-6634B746-EA5C-499D-B83E-E03440B28338Q46669053-50A449F1-FA6D-4CA6-A7EC-67DAF5F4A764Q47115193-C20772FC-19C2-4C84-B929-8C6913282F35Q47920712-8DF396CA-A212-4A43-8E3D-677808E3711A
P2860
Mammalian target of rapamycin signaling in diabetic cardiovascular disease
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mammalian target of rapamycin signaling in diabetic cardiovascular disease
@ast
Mammalian target of rapamycin signaling in diabetic cardiovascular disease
@en
type
label
Mammalian target of rapamycin signaling in diabetic cardiovascular disease
@ast
Mammalian target of rapamycin signaling in diabetic cardiovascular disease
@en
prefLabel
Mammalian target of rapamycin signaling in diabetic cardiovascular disease
@ast
Mammalian target of rapamycin signaling in diabetic cardiovascular disease
@en
P2860
P921
P356
P1476
Mammalian target of rapamycin signaling in diabetic cardiovascular disease
@en
P2093
Kenneth Maiese
Zhao Zhong Chong
P2860
P2888
P356
10.1186/1475-2840-11-45
P407
P5008
P577
2012-07-16T00:00:00Z
P5875
P6179
1042344043